Na Li

Experience

• 

  Xi'an Jiaotong University

  Jan 1997 - Jan 1998

  Medical Internship
• 

  Community hospital in Xi'an, China

  Jan 1998 - Jan 2002

  Medical Doctor

  Practicing Physician (Internal Medicine)

• 

  BGI Genomics

  Jan 2005 - Jan 2008

  Project Manager

  Genomic sequencing projects and Clinical Lead for a hypoxia-induced pulmonary hypertension research project

• 

  Johnson & Johnson

  Jan 2008 - Jan 2018

  Therapeutic Area Lead, Solid Tumors On an International Development Executive program from JNJ. Worked on global registration studies focusing on technical competencies in therapeutic areas. Also served as Global Compound Development Team member. China TA lead in Hematology, led and directed the clinical development of Heme compounds in JNJ pipelines in China. In addition, been taking the role of China Compound Team Leader for high priority compound. Other roles including clinical advisor in AP region TA Strategy Team in Oncology, etc.

  • Associate Director Clinical Research

    Jan 2017 - Jan 2018

  • Clinical Director

    Jan 2015 - Jan 2017

  • Sr. Clinical Development Physician and Manager

    Jan 2008 - Jan 2015
• 

  Roche

  Jul 2018 - Oct 2021

  Hematology Disease Area Lead responsible for Hematology portfolio and product development including strategy and clinical activites

  • Sr. Product Development Medical Director, a.i. PD Onco/Heme China site head

    Aug 2020 - Oct 2021

  • Sr. Product Development Medical Director

    Jul 2018 - Oct 2021
• 

  Sumgen Biotech Co., Ltd.

  Jan 2022 - now

  Vice President Clinical Research